← 返回

恶性黑色素瘤患者移行转移的预后因素

英文原题:Prognostic factors for in-transit metastasis in patients with malignant melanoma.

查看英文原题

Prognostic factors for in-transit metastasis in patients with malignant melanoma.

PubMed 2022/01/31(内容时间) Med Pharm Rep

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

发生于胸部的原发性皮肤黑色素瘤出现区域性疾病的风险高,而其他临床病理特征无法用于预测局部复发。

中文摘要

恶性黑色素瘤具有侵袭性且难以预测,无论肿瘤分期和治疗方式如何,局部区域复发率均较高。本研究旨在鉴定恶性黑色素瘤患者发生移行转移的主要组织病理学预后因素。

仅纳入 2010–2021 年在综合癌症中心治疗、确诊恶性黑色素瘤且组织学证实移行转移的患者。研究评估组织病理学参数,并进行单变量和多变量分析。

共纳入 26 例患者。单变量和多变量分析均显示,仅原发于胸部皮肤的黑色素瘤与移行转移风险相关;Breslow 厚度和 Clark 分级较高、存在溃疡、淋巴结阳性、TIL 密度不旺盛、核分裂率高、结节型亚型及年龄>50 岁等临床病理因素可能是风险因素,但未能发现统计学相关性。

原发于胸部皮肤的黑色素瘤发生局部区域疾病风险较高,其他临床病理特征无法用于预测局部复发。仍需开展前瞻性、更大规模队列研究验证这些重要预后因素。

展开英文摘要原文

The study includes only patients that were diagnosed with malignant melanoma and with histologically confirmed in-transit metastasis who were treated in a comprehensive cancer center between 2010-2021. Histopathological parameters were investigated, univariate and multivariate analysis was performed.

A total of 26 patients were included in the analysis. On univariate and multivariate analysis, only primary cutaneous melanomas located on the thorax correlated with the risk of developing in-transit metastasis, whereas clinicopathological factors such as an increased Breslow thickness and Clark level, the presence of ulceration, positive lymph nodes, a non-brisk TIL density, a high mitotic rate, a nodular subtype, and age >50 years may represent risk factors, even though we could not find any correlations.

Primary cutaneous melanomas that arise on the thorax present a high risk for the occurrence of locoregional disease, whereas other clinicopathological characteristics could not be used to predict local recurrence. However, prospective and more extensive cohort studies are needed in order to validate these important prognostic factors.

论文信息

作者
Gâta VA、Roman A、Muntean M、Morariu DŞ、Vlad CI、Bonci EA、Irimie A、Achimaş-Cadariu P
单位
Department of Oncology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.Italy
期刊
Medicine and pharmacy reports2022 Jan
原文标识
PubMed 35720233 · DOI 10.15386/mpr-2173